| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6109598 | Journal of Hepatology | 2009 | 8 Pages |
Abstract
By removing all possible adenomatous tissue and reversing the underlying hepatic enzymatic deficiency, LT provides definitive prevention against HCC and correction of most metabolic derangements in GSD Ia patients. Renal dysfunction secondary to GSD Ia persists-underscoring the need for further studies to better understand the mechanisms of renal dysfunction in these patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Srinevas K. Reddy, Stephanie L. Austin, Michele Spencer-Manzon, Dwight D. Koeberl, Bryan M. Clary, Dev M. Desai, Alastair D. Smith, Priya S. Kishnani,